Literature DB >> 10761636

Remodeling of elastic fiber components in scleroderma skin.

E C Davis1, S A Blattel, R P Mecham.   

Abstract

The skin of patients with scleroderma is characterized by an excess accumulation of collagen in the extracellular matrix of the fibrotic reticular dermis. Elastic fibers are also disrupted in this disease, however, in contrast to collagen, relatively few studies have provided information concerning the changes that occur to elastic fiber components in scleroderma. In the present study, the extracellular matrix in scleroderma skin was examined with a specific focus on the integrity of elastic fibers. Electron microscopic observations confirmed an excess of 10 nm microfibrils present in small bundles independent of amorphous elastin in the fibrotic reticular dermis. In the same area, a population of stellate-shaped fibroblasts was identified in close association with the dermal elastic fibers. In contrast to the uniform black appearance of the elastic fibers seen in the papillary dermis and in areas of the reticular dermis not infiltrated by these cells, the elastic fibers apposed to the cells were mottled in density and often almost electron-lucent. These observations suggest that the elastic fibers in the reticular dermis were being actively degraded. Results from this study provide evidence for disintegration of elastic fibers in the skin of scleroderma patients and suggest the possibility that degradation products from the elastic matrix in the diseased tissues may act as a feedback signal for increased matrix production.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10761636     DOI: 10.3109/03008209909029107

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  8 in total

1.  Antagonistic effect of the matricellular signaling protein CCN3 on TGF-beta- and Wnt-mediated fibrillinogenesis in systemic sclerosis and Marfan syndrome.

Authors:  Raphael Lemaire; Giuseppina Farina; Julie Bayle; Michael Dimarzio; Sarah A Pendergrass; Ausra Milano; Bernard Perbal; Michael L Whitfield; Robert Lafyatis
Journal:  J Invest Dermatol       Date:  2010-02-25       Impact factor: 8.551

2.  Restoring elastin with microRNA-29.

Authors:  Xiu Rong Dong; Mark W Majesky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03       Impact factor: 8.311

3.  Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome.

Authors:  B L Loeys; E E Gerber; D Riegert-Johnson; S Iqbal; P Whiteman; V McConnell; C R Chillakuri; D Macaya; P J Coucke; A De Paepe; D P Judge; F Wigley; E C Davis; H J Mardon; P Handford; D R Keene; L Y Sakai; H C Dietz
Journal:  Sci Transl Med       Date:  2010-03-17       Impact factor: 17.956

Review 4.  Matrix-dependent perturbation of TGFβ signaling and disease.

Authors:  Jefferson J Doyle; Elizabeth E Gerber; Harry C Dietz
Journal:  FEBS Lett       Date:  2012-05-26       Impact factor: 4.124

5.  Analysis of dermal elastic fibers in the absence of fibulin-5 reveals potential roles for fibulin-5 in elastic fiber assembly.

Authors:  Jiwon Choi; Andreas Bergdahl; Qian Zheng; Barry Starcher; Hiromi Yanagisawa; Elaine C Davis
Journal:  Matrix Biol       Date:  2009-03-24       Impact factor: 11.583

6.  Tight Skin 2 Mice Exhibit Delayed Wound Healing Caused by Increased Elastic Fibers in Fibrotic Skin.

Authors:  Kristen B Long; Chelsea M Burgwin; Richard Huneke; Carol M Artlett; Elizabeth P Blankenhorn
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-09-01       Impact factor: 4.730

7.  Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin.

Authors:  Yoshihide Asano; Margaret Markiewicz; Masahide Kubo; Gabor Szalai; Dennis K Watson; Maria Trojanowska
Journal:  Mol Cell Biol       Date:  2008-11-10       Impact factor: 4.272

8.  Serum elastin-derived peptides and anti-elastin antibody in patients with systemic sclerosis.

Authors:  Yoo Jin Hong; Jinhyun Kim; Bo Ram Oh; Yun Jong Lee; Eun Young Lee; Eun Bong Lee; Seung-Hyo Lee; Yeong Wook Song
Journal:  J Korean Med Sci       Date:  2012-04-25       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.